🇺🇸 FDA
Patent

US 8501740

Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors

granted A61KA61K31/00A61K31/485

Quick answer

US patent 8501740 (Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors) held by The Board of Regents of the University of Texas System expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/00, A61K31/485, A61K31/506, A61K31/517